Cardlytics (CDLX) Tops Q2 EPS by 31c

Cardlytics (NASDAQ: CDLX) reported Q2 EPS of ($0.15), $0.31 better than the analyst estimate of ($0.46). Revenue for the quarter came in at $69.64 million versus the consensus estimate of $75.39 million.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Home Depot (HD) call put ratio 1.5 calls to 1 put with a focus on September 330 puts into quarter results
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery